Mary W. Richardson

Mary W. Richardson, Christopher A. Colvin | Kramer Levin Naftalis & Frankel LLP

Since 1982, the Court of Appeals for the Federal Circuit ("CAFC") has had jurisdiction over patent appeals, and has attempted to bring greater uniformity and predictability to patent law.1The CAFC has fashioned precedent generally perceived as strengthening patentees' rights. The Supreme Court...

Mary W. Richardson, Nicholas L. Coch | Kramer Levin Naftalis & Frankel LLP

On January 9, 2007, the Supreme Court issued its decision in MedImmune, Inc. v. Genentech, Inc., holding that a patent licensee (MedImmune in this case) has standing to sue for a declaratory judgment of invalidity, unenforceability or noninfringement of a licensor's (i.e., Genentech's) patent even...

George B. Snyder, Mary W. Richardson | Kramer Levin Naftalis & Frankel LLP

In today's marketplace new technology is one of a business' most valuable assets. However, deployment of new technology is a double-edged sword because it can lead to significant exposure, in particular patent infringement liability. Accordingly, a business must be able to assess beforehand whether...